P2X3 receptor antagonist patent, Beijing Tide Pharma, 6 claims
Summary
P2X3 receptor antagonist patent, Beijing Tide Pharma, 6 claims
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof
Grant US12595261B2 Kind: B2 Apr 07, 2026
Assignee
BEIJING TIDE PHARMACEUTICAL CO., LTD.
Inventors
Yanping Zhao, Hongjun Wang, Yeming Wang, Liying Zhou, Yanan Liu
Abstract
Disclosed are a P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition containing same, and the use thereof for preventing or treating a disease regulated by the P2X3 and/or P2X2/3 receptor antagonist.
CPC Classifications
C07D 471/04 C07D 491/048 C07D 495/04 C07D 498/04 C07D 513/04 A61P 29/00 A61P 11/00 A61K 31/506
Filing Date
2020-06-05
Application No.
17616236
Claims
6
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.